Absolute Bioavailability of BMS-791325

Clinical trial NCT02112110 · COMPLETED

Trial details

NCT number: NCT02112110
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis C Virus Infection

Start date: 2014-04-01
Primary completion: 2014-05-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.